UK markets open in 5 hours 18 minutes

SOL S.p.A. (0NJP.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
34.95+0.45 (+1.31%)
At close: 05:00PM BST

SOL S.p.A.

Via Borgazzi, 27
Monza, MI 20900
Italy
39 03 923961
https://www.solgroup.com

Sector(s)
Industry
Full-time employees6,372

Key executives

NameTitlePayExercisedYear born
Engineer Aldo Fumagalli RomarioChairman, Co-CEO & MD577.46kN/A1958
Mr. Marco AnnoniDeputy Chairman, Co-CEO & MD577.96kN/A1961
Mr. Giulio Fumagalli RomarioDirector of Legal & Corporate Business and Director573.6kN/A1964
Mr. Giovanni AnnoniDirector of Information Systems & Director578.24kN/A1959
Marco FilippiCFO & ManagerN/AN/AN/A
Ms. Alessandra AnnoniExecutive Director12kN/A1960
Duccio AlbertiExecutive DirectorN/AN/A1952
Amounts are as of 31 December 2015, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use and liquefied natural gas. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids. In addition, the company provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services. Further, the company designs and develops bio banks; supplies technical gases; offers pre-and post-natal diagnostic screening services; develops diagnostic systems; researches, develops, produces, and markets products for research, diagnosis, and clinical application in the hospital, environmental, veterinary, and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples. Its products are used in the chemical, electronics, iron and steel, metal, engineering and foodstuff industries, as well as in environmental protection, and research and healthcare sectors. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Stichting Airvision BV.

Corporate governance

SOL S.p.A.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 7; Board: 10; Shareholder rights: 3; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.